BCL-2 as therapeutic target for hematological malignancies

Overview of attention for article published in Journal of Hematology & Oncology, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 35,187 followers.

RT @guiperini: Our review on BCL-2 as therapeutic target for hematological malignancies https://t.co/s5qcvysIHy

RT @guiperini: Our review on BCL-2 as therapeutic target for hematological malignancies https://t.co/s5qcvysIHy

RT @guiperini: Our review on BCL-2 as therapeutic target for hematological malignancies https://t.co/s5qcvysIHy

BCL-2 as therapeutic target for hematological malignancies [5/11/18] Perini et al. J Hematol Oncol https://t.co/OC0s9zMxGu

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.